AI/ML Innovations Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AIMLF research report →
Price Chart
About the company
Operating within the digital healthcare sector, AI/ML Innovations Inc. harnesses the power of artificial intelligence (AI) and machine learning (ML). The company's central offering is a patent-pending system for personal health monitoring and management, crafted to enable caregivers, patients, and medical professionals to readily access and utilize data.
- CEO
- John Paul Duffy
- IPO
- 1996
- Employees
- 5
- HQ
- Victoria, BC, CA
Get TickerSpark's AI analysis on AIMLF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
- Market Cap
- $4.88M
- P/E
- -1.72
- PEG
- -0.05
- P/S
- 307.33
- P/B
- -6.00
- EV/EBITDA
- -2.41
- Div Yield
- 0.00%
- Gross Margin
- -1416.94%
- Op Margin
- -15255.77%
- Net Margin
- -15074.13%
- ROE
- 2759.13%
- ROIC
- -1168.17%
Latest fiscal year · YoY change
- Revenue
- $83.03K-50.4%
- Gross Profit
- $-2,748,637-1788.3%
- Op Income
- $-6,485,733
- Net Income
- $-6,353,455.3-38.3%
- EPS
- $-0.03+21.8%
- OCF Growth
- -35.3%
- FCF Growth
- -35.4%
- 52W High
- $0.06
- 52W Low
- $0.00
- 50D MA
- $0.03
- 200D MA
- $0.03
- Beta
- 1.18
- RSI (14)
- 46
- Avg Volume
- 56.61K
No earnings-call transcripts are available for AIMLF yet.
- Free Float
- 43.1%
- Shares Outstanding
- 168.26M
- Float Shares
- 72.45M
Our AIMLF coverage
Recent articles, reports, and earnings notes.
No research on AIMLF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate AIMLF report →AI/ML Innovations Announces Completion of Share Issuance
accessnewswire.com · Oct 13
AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
accessnewswire.com · Oct 2
AIML Subsidiary NeuralCloud Signs Binding Commercial Term Sheet with VetMed Consultants for MaxYield(TM) ECG Services
accessnewswire.com · Oct 1
AIML Subsidiary NeuralCloud Enters Strategic Partnership with RKS Medical Technologies to Advance CardioYield(TM) Clinical Pilots
accessnewswire.com · Sep 29
AI/ML Innovations Launches Quantum Soma Initiative with Dynex Quantum Technologies for Contactless Quantum Biosensing Platform
accessnewswire.com · Sep 21
AI/ML Innovations Inc. Closes Final Tranche of Private Placement
accessnewswire.com · Sep 14
AI/ML Innovations subsidiary NeuralCloud Appoints Former FDA Reviewer Dr. Mehmet Kosoglu as the Head of Regulatory Affairs
accessnewswire.com · Sep 1
AI/ML Innovations Inc. Closes First Tranche of Private Placement
accessnewswire.com · Aug 26
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.